logo
Book a meeting
Covira

Covira

Biotechnology, 225 Ne 97th St, North Chicago, Illinois, 73114, United States, 1-10 Employees

covirasurgical.com

  • facebook
  • twitter
  • LinkedIn

Who is COVIRA

Covira is an early-stage biotech company, a spinout from The University of Chicago (Sept 2018). This microbiome-focused company is based on the work of Dr. John Alverdy, MD, a world autho...

Read More

lock icon Get Full Access
map
  • 225 Ne 97th St, North Chicago, Illinois, 73114, United States Headquarters: 225 Ne 97th St, North Chicago, Illinois, 73114, United States
  • 2018 Date Founded: 2018
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731 | NAICS Code: 541715 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from COVIRA

Covira Org Chart and Mapping

Employees
Jeff Schaffnit

Jeff Schaffnit

Advisory Board Member

Kaitlyn Read

Kaitlyn Read

Product Development Scientist

See Full Org Chart arrow
email-formate-icon
View Email Formats for Covira
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Covira

Answer: Covira's headquarters are located at 225 Ne 97th St, North Chicago, Illinois, 73114, United States

Answer: Covira's official website is https://covirasurgical.com

Answer: Covira's revenue is $1 Million to $5 Million

Answer: Covira's SIC: 8731

Answer: Covira's NAICS: 541715

Answer: Covira has 1-10 employees

Answer: Covira is in Biotechnology

Answer: Covira contact info: Phone number: Website: https://covirasurgical.com

Answer: Covira is an early-stage biotech company, a spinout from The University of Chicago (Sept 2018). This microbiome-focused company is based on the work of Dr. John Alverdy, MD, a world authority on the molecular basis of post-surgical infections. Covira's focus is to develop drugs that work by modulating the biological activity of the gut microbiome's resident bacteria. Coviras lead asset (CS-0003) is a platform technology that modulates bacterial virulence and restores microbial communities to prevent post-surgical infection. CS-0003 is transformative to the field and the world is taking notice...in the 4th quarter of last year Business Worldwide Magazine named Covira Among the 2021- Top 20 Most Innovative Companies to Watch.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access